Paul TheisenPatient Acquisition
Brenda SnowAuthentic Patient Voice
Frank BurrellScientific Storytelling
Bud BilanichSuccess Coach
Suma Ramadas, PhDMedical Affairs
Daniel SontupeMarket Access
Stacey GandlerBrand Nourishment
Pat PurcellMeeting Engagement
Matt TurnerPatient Affordability
Liz KaneImpactful Strategy
Amy GilesIncreasing Engagement
Joey CohenMedication Adherence
David LinetskyPoint-of-Care Marketing
Matthew DurhamOmnidynamic Marketing
NEW YORK, Sept. 14, 2017 (GLOBE NEWSWIRE) -- Tyme Technologies, Inc. (Nasdaq:TYME), a biotechnology ...
– Tipifarnib is a CXCL12 pathway inhibitor that may provide clinical benefit in subsets ...
Username
Email
Password
Confirm Password
Remember Me
Username or Email